Hepatitis E Virus Antibodies in Blood Donors, France
Jean-Michel Mansuy, Richard Bendall, Florence Legrand-Abravanel, Karine Sauné, Marcel Miédouge, Vic Ellis, Henri Rech, François Destruel, Nassim Kamar, Harry R. Dalton, and Jacques Izopet
Author affiliations: Hôpital Purpan, Toulouse, France (J.-M. Mansuy, F. Legrand-Abravanel, K. Sauné, M. Miédouge, J. Izopet); Royal Cornwall Hospital Trust, Truro, UK (R. Bendall, V. Ellis, H.R. Dalton); Institut National de la Santé et de la Recherche Médicale, Toulouse (F. Legrand-Abravanel, K. Sauné, N. Kamar, J. Izopet); Université Toulouse III Paul Sabatier, Toulouse (K. Sauné, N. Kamar, J. Izopet); Etablissement Français du Sang Pyrénées-Méditerranée, Toulouse (H. Rech, F. Destruel); Peninsula College of Medicine and Dentistry, Truro (H.R. Dalton); Hôpital Rangueil, Toulouse (N. Kamar)
Figure 2. Distribution of optical density/cut off ratios for hepatitis E virus IgG in positive and negative samples from 512 blood donors, Midi-Pyrénées region, France, 2003–2004. Whiskers represent percentiles.
Page created: November 30, 2011
Page updated: November 30, 2011
Page reviewed: November 30, 2011
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.